Adaptation, PsychologicalAntineoplastic Combined Chemotherapy ProtocolsBridged Bicyclo Compounds, Heterocyclic
Dr. Matthew Charles Foster, MD
NPI1902923253
- Medicare services, 2022
- 374
- Part D claims, 2022
- 259
- Publications
- 68
- Clinical trials
- 15
- Industry payments
- $71,234
- Practice address
- 101 Manning Dr, Chapel Hill, NC 27514
- Practice phone
- Call (984) 974-1000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
UNC Hospitals
Chapel Hill, North Carolina
Find Dr. Foster's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Matthew Charles Foster is an internist in Chapel Hill, North Carolina
Dr. Foster practices at UNC Hospitals in Chapel Hill, North Carolina.
Dr. Foster's NPI, 1902923253, was assigned on March 23, 2007. Dr. Foster graduated from University of North Carolina School of Medicine in 2002. Dr. Foster holds North Carolina license 200500704.
NPI and contact details
- NPI
- 1902923253NPI Registry (opens in a new tab)
- NPI enumeration date
- March 23, 2007
- NPI status
- Active
- Practice phone
- (984) 974-1000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 50
- Medical school graduation
- 2002
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Practice Data
Dr. Matthew Charles Foster practices at UNC Hospitals in Chapel Hill, North Carolina
Dr. Foster's primary practice is UNC Hospitals, at 101 Manning Dr, Chapel Hill, NC 27514 in Orange County. The practice phone is (984) 974-1000.
- UNC Hospitals101 Manning Dr, Chapel Hill, NC 27514 · Orange CountyPhone(984) 974-1000
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Matthew Charles Foster is affiliated with 1 site of care
Dr. Foster's primary practice is UNC Hospitals in Chapel Hill, North Carolina.
UNC HospitalsPrimary
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Dr. Matthew Charles Foster's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Foster practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| UNC Hospitals | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Foster practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Matthew Charles Foster is one of 3,705 internists in North Carolina
Internal medicine is Dr. Foster's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Foster is board certified in hematology by the American Board of Internal Medicine. Dr. Foster is licensed in North Carolina.
Specialties and state licenses
- Internal medicine, North CarolinaPrimary
Internists near Dr. Foster
Counts of internists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Matthew Charles Foster billed Medicare for 374 services in 2022
CMS data shows 374 Medicare services from Dr. Foster across 5 procedure codes in 2022. Medicare paid $32,958 for them. Every service was in a facility, such as a hospital, rather than an office.
Medicare services, 2022374
Paid by Medicare$32,958
Procedure codes5
Dr. Foster's Medicare services by type, 2021 to 2022
- 2021
- 2022
- Office and hospital visits
- 2021: 4342022: 37414%
Dr. Foster compared with the North Carolina median for internists, 2022
- Dr. Foster
- North Carolina median
- Medicare services
- 374vs 52128% below
- Part D claims
- 259vs 272Close to median
Medians across 3,695 internists in North Carolina with Dmand AI profiles that report each measure.
Dr. Foster's most billed Medicare procedure codes, 2022
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Foster?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Foster and other internists in North Carolina.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Matthew Charles Foster's patients have a median age of 72
Across all payers, Dmand AI patient panel data puts Dr. Foster's median patient age at 72, with 50% women.
Dr. Foster's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 72
Patient panel by sex, all payers
- Women50%
- Men50%
Source: Dmand AI Patient Panel Data
Dr. Matthew Charles Foster wrote 259 Medicare Part D claims in 2022
In 2022, Dr. Foster wrote 259 Medicare Part D claims. They cover 10 drugs, with $2,450,839 in total drug cost. In 2021, CMS named 345 claims across 12 drugs.
Part D claims, 2022259
Drugs named by CMS10
Total drug cost$2.5M
Dr. Foster's most prescribed drugs by claims, 2022
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2021 to 2022
- 2021
- 2022
- Claims for drugs CMS names
- 2021: 3452022: 25925%
Drugs named by CMS: 10 in 2022, 12 in 2021.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
For MedTech and pharma teams
Find internists like Dr. Foster by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Matthew Charles Foster has 68 publications on record
Dmand AI links 68 papers to Dr. Foster, published from 2009 to 2024. 2019 was the busiest year, with 10. The most frequent topics are Leukemia, Myeloid, Acute, Antineoplastic Combined Chemotherapy Protocols and Antineoplastic Agents. Dr. Foster has published most often in Leuk Lymphoma. Dr. Foster's most frequent co-authors are Catherine C. Coombs, MD, Daniel R. Richardson, MD and Anjali S. Advani, MD.
Papers68
Years published2009 to 2024
Dr. Foster's papers by year, 2015 to 2024
Topics Dr. Foster writes about most
- Leukemia, Myeloid, Acute
- Antineoplastic Combined Chemotherapy Protocols
- Antineoplastic Agents
- Bridged Bicyclo Compounds, Heterocyclic
- Cytarabine
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Antibodies, Monoclonal, Humanized
- Azacitidine
Dr. Foster's most frequent co-authors
- Catherine C. Coombs, MD14 shared papers
- Daniel R. Richardson, MD9 shared papers
- Anjali S. Advani, MD5 shared papers
Recent publications by Dr. Foster
GenomicsLeukemia, Myeloid, AcuteMyeloproliferative Disorders
Antineoplastic AgentsCommunicationDelivery of Health Care
See who Dr. Foster researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Foster works with, so you can find a warm path to the right internists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Matthew Charles Foster has worked on 15 clinical trials
Dmand AI links Dr. Foster to 15 clinical trials, 5 of them phase 3 studies. 7 are still active or recruiting. Conditions studied include Leukemia, Myeloid, Acute, Leukemia, Myeloid and Epstein-Barr Virus Infections. National Cancer Institute (NCI) sponsors the most, 6.
Clinical trials with Dr. Foster by phase
- 3Phase 1: 3 trials
- 3Phase 1/2: 3 trials
- 3Phase 2: 3 trials
- 1Phase 2/3: 1 trial
- 5Phase 3: 5 trials
- NonePhase 4: no trials
Conditions in Dr. Foster's trials
- Leukemia, Myeloid, Acute
- Leukemia, Myeloid
- Epstein-Barr Virus Infections
- Burkitt Lymphoma
- Leukemia, Lymphocytic, Chronic, B-Cell
Investigators on the most trials with Dr. Foster
- Grerk Sutamtewagul, MD4 shared trials
- Craig Stephen Boddy, MD3 shared trials
- Emily Kathleen Curran, MD3 shared trials
Recent clinical trials with Dr. Foster
Burkitt LymphomaEpstein-Barr Virus InfectionsBlinatumomabInotuzumab Ozogamicin
A Randomized Phase II/III Study of Conventional Chemotherapy +/- Uproleselan (GMI-1271) in Older Adults With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy (opens in a new tab)
Active, not recruitingPhase 2/3
Leukemia, Myeloid, AcuteLeukemia, MyeloidUproleselanCytarabineDaunorubicin
Leukemia, Myeloid, AcuteLeukemia, MyeloidCPI-613 + High Dose Cytarabine and MitoxantroneFludarabine, Cytarabine, FilgrastimHigh Dose Cytarabine and Mitoxantrone
Assessing the Ability of Combination Treatment With Venetoclax to Permit Time Limited Therapy in Chronic Lymphocytic Leukemia (opens in a new tab)
Active, not recruitingPhase 3
Leukemia, Lymphocytic, Chronic, B-CellLeukemia, B-CellVenetoclaxIbrutinibObinutuzumab
Testing the Addition of a New Anti-cancer Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Obinutuzumab) in Untreated, Older Patients With Chronic Lymphocytic Leukemia (opens in a new tab)
Active, not recruitingPhase 3
Leukemia, Lymphocytic, Chronic, B-CellLeukemia, B-CellIbrutinibObinutuzumabVenetoclax
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Matthew Charles Foster received $71,234 in industry payments from 2016 to 2023
CMS Open Payments shows 49 general payments to Dr. Foster from 7 drug and device companies from 2016 to 2023. Consulting fees make up the largest share, 93% of the total. Daiichi Sankyo Inc. paid the most, $48,980.
General payments to Dr. Foster by program year, 2016 to 2023
General payments to Dr. Foster by kind, 2016 to 2023
$71.2Kin total
- Consulting fees$66,39593%
- Travel and lodging$3,9125%
- Food and beverage$8841%
- Compensation for serving as faculty or as a speaker for a medical education program$430%
Companies that paid Dr. Foster the most, 2016 to 2023
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Matthew Charles Foster has 1 award and honors on record
Dmand AI lists 1 award for Dr. Foster, most recently CMS Stage 1 2012 in 2012.
Awards and honors for Dr. Foster
- 2012
- CMS Stage 1 2012
Source: Dmand AI Professional Profile Data
Dr. Matthew Charles Foster graduated from University of North Carolina School of Medicine
Dr. Foster graduated from University of North Carolina School of Medicine in 2002. Dr. Foster is a member of ASCO.
- Medical school
- Board certified in hematology
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Dr. Matthew Charles Foster accepts plans from 3 insurance carriers
Dr. Foster is in network with 3 carriers, including Cigna, Amerihealth Caritas and NC State Medicaid. Medicaid plans come from the most carriers, 2. Check the plan with the practice before a visit.
- Cigna
- Amerihealth Caritas
- NC State Medicaid
Plan types Dr. Foster accepts, by number of carriers
- Medicaid2
- HMO1
- Medicare1
- PPO1
Source: Dmand AI Insurance Network Data
Sources for Dr. Matthew Charles Foster's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Matthew Charles Foster
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Matthew Charles Foster's NPI number?
Dr. Matthew Charles Foster's NPI number is 1902923253. It was assigned on March 23, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Matthew Charles Foster?
Dr. Matthew Charles Foster is an internist in Chapel Hill, North Carolina. The primary specialty in the NPI Registry is Internal Medicine Physician (taxonomy code 207R00000X).
Where does Dr. Matthew Charles Foster practice?
Dr. Foster practices at 101 Manning Dr, Chapel Hill, NC 27514. Dr. Foster's primary practice is UNC Hospitals in Chapel Hill, North Carolina.
What is Dr. Matthew Charles Foster's office phone number?
The practice phone on file for Dr. Foster is (984) 974-1000.
What is Dr. Matthew Charles Foster's medical license number?
Dr. Foster holds North Carolina license 200500704.
Does Dr. Matthew Charles Foster accept Medicare?
Yes. CMS data shows Dr. Foster billed Medicare for 374 services in 2022.
Is Dr. Matthew Charles Foster board certified?
Yes. Dr. Foster is board certified in hematology by the American Board of Internal Medicine.
What services does Dr. Matthew Charles Foster bill to Medicare?
In 2022, Dr. Foster's most billed Medicare services were hospital inpatient care (99233), office visit, established patient (99215) and office visit, established patient (99214).
Where did Dr. Matthew Charles Foster go to medical school?
Dr. Foster graduated from University of North Carolina School of Medicine in 2002.
What drugs does Dr. Matthew Charles Foster prescribe most?
In 2022 Medicare Part D data, Dr. Foster's most prescribed drugs by claims were Venclexta, Jakafi and Imatinib Mesylate.
Show 5 more questionsShow fewer questions
Has Dr. Matthew Charles Foster received payments from drug or device companies?
CMS Open Payments shows $71,234 in general payments to Dr. Foster from 7 companies from 2016 to 2023. The largest total came from Daiichi Sankyo Inc.
How long has Dr. Matthew Charles Foster been practicing?
Dr. Foster graduated from medical school in 2002, 24 years ago.
Does Dr. Matthew Charles Foster do research?
Dmand AI links 68 publications to Dr. Foster, published from 2009 to 2024. Dr. Foster has worked on 15 clinical trials.
Who does Dr. Matthew Charles Foster publish with?
Dr. Foster's most frequent co-authors are Catherine C. Coombs, MD (14 shared papers), Daniel R. Richardson, MD (9 shared papers) and Anjali S. Advani, MD (5 shared papers).
What insurance does Dr. Matthew Charles Foster accept?
Dr. Foster is in network with 3 carriers, including Cigna, Amerihealth Caritas and NC State Medicaid. Medicaid plans come from the most carriers, 2. Check the plan with the practice before a visit.
Selling to internal medicine practices?
See internists in North Carolina by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card